Seeking Alpha

Receptos prices stock offering

  • Receptos (RCPT) prices its public offering of 4,433,000 shares of common stock at $40.25/share. Underwriters over-allotment is 664,950 shares. Closing date is June 24.
  • Net proceeds will be used to fund the continued development of RPC1063 in clinical trials for relapsing multiple sclerosis and ulcerative colitis, the development of its in-licensed product candidate RPC4046 for eosinophilic esophagitis, other research programs and for general corporate purposes.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs